Discussing and Advancing Trusted Information Architecture for AI Innovation in Life Sciences (IA4AI)
Join senior leaders across R&D, Manufacturing, Quality, Regulatory, Clinical and Commercial functions for curated peer discussions and practical AI strategy sessions designed specifically for Life Science enterprises.
The AI Innovation Circle for Life Sciences connects forward-thinking leaders exploring how trusted, governed AI can accelerate innovation, operational efficiency, scientific discovery and enterprise transformation
Through collaborative workshops and executive virtual forums, members explore practical applications of Information Architecture 4 Artificial Intelligence (IA4AI):
Each session is focused on real-world implementation challenges, measurable business outcomes and responsible AI adoption across regulated environments.

How to build a life science semantic graph.
Drew Wanczowski, Jim Morris, Imran Chaudhri and Don Miller

Why memory, not models, is becoming the critical differentiator for enterprise AI and reducing tokenization costs.
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How should we organize and model enterprise knowledge for enterprise AI in life sciences?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How do we operationalize semantic models?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How do AI systems find and use trusted information?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How do agents reason, plan and act?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How do we safely deploy agents in regulated environments?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller

How do we justify, measure and scale investments?
Drew Wanczowski, Jim Morris, Imran Chaudhri, Biju George and Don Miller
Five regulars and a rotating bench of guests from across the Life Sciences community. The cast brings strategy, community and product perspective, and featured guests offer insights to enrich wherever the conversation goes.
10+ years building search, GenAI and agentic AI solutions for life sciences
15+ years at Astra Zeneca and 30+ years building Life Sciences solutions
20 years working in publishing & media focusing on news, scientific domains and R&D
Chief Architect with 12+ years of experience building healthcare and Life Sciences solutions
Sr. Principal Solutions Engineer with 20+ years of experience building healthcare and Life Sciences solutions
R&D leaders, engineers and members of customer-facing teams
Every month is its own conversation, but a few themes keep surfacing across R&D, clinical, regulatory, quality, manufacturing, medical affairs, commercial and patient services. These are the threads that connect the life sciences enterprise and conversations the industry cannot keep avoiding.
Connecting discovery, preclinical, clinical, real-world evidence, literature and external science to accelerate decisions across both Good "x" Practice (GxP) and non-GxP environments. Transforming fragmented scientific knowledge into actionable enterprise intelligence.
Building AI systems that are explainable, compliant, auditable and trusted by scientists, clinicians, regulators, quality teams and business stakeholders. Facilitating AI that can be adopted safely across regulated and non-regulated functions.
Creating the contextual foundation that connects data, documents, concepts, processes and expertise across the organization. Providing the meaning, provenance and governance necessary for scalable AI.
Exploring how AI moves beyond answering questions to supporting and automating complex workflows across R&D, clinical operations, regulatory affairs, quality, manufacturing, medical affairs and commercial functions.
Applying AI and data intelligence to improve development, supply chain, manufacturing, quality operations and inspection readiness while reducing cost, risk and cycle times.
Understanding the business realities of enterprise AI, including tokenization costs, infrastructure spend, operating models, productivity gains and hard-dollar business outcomes. Focusing on scaling initiatives that demonstrate measurable value.
Join us live and bring a question or just listen in.
Episode 02 drops soon.